Related Experiment Video
Updated: Dec 17, 2025

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
Prothrombotic state induced by COVID-19 infection as trigger for stroke in young patients: A dangerous association
Francesco Cavallieri1,2, Alessandro Marti1, Antonio Fasano1,2
1Neurology Unit, Neuromotor & Rehabilitation Department, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Insights
COVID-19 infection can cause inflammation and blood clots, potentially leading to strokes even in young individuals. Physicians should consider stroke as an early sign of coronavirus disease 2019 (COVID-19).
Area of Science:
- Neurology
- Infectious Diseases
- Cardiology
Background:
- COVID-19 infection is associated with a pro-inflammatory and pro-thrombotic state.
- Cerebrovascular complications have been reported in patients with COVID-19.
Purpose of the Study:
- To highlight the potential for cerebrovascular involvement in COVID-19.
- To emphasize that stroke can be an initial manifestation of COVID-19.
Main Methods:
- Review of clinical data and relevant literature on COVID-19 and cerebrovascular events.
- Analysis of patient cases presenting with stroke and subsequent COVID-19 diagnosis.
Main Results:
- COVID-19 infection can induce a pro-inflammatory and pro-thrombotic state.
- Cerebrovascular events, including stroke, can occur in COVID-19 patients, including younger demographics.
- Stroke may present as the primary symptom of COVID-19 infection.
Conclusions:
- Healthcare providers must recognize the risk of stroke in COVID-19 patients.
- Cerebrovascular complications should be considered in the differential diagnosis of stroke, particularly during the pandemic.
- Early recognition of stroke as a potential COVID-19 symptom is crucial for timely management.
Abstract:
•COVID-19 infection could led to a pro-inflammatory and pro-thrombotic state.•Cerebrovascular involvement may occur in COVID-19 infection even in young patients.•Physicians should be aware that stroke may be the first COVID-19 manifestation.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis I: Introduction
Pulmonary Embolism I: Introduction
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

